Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds
Shares are down 70% for the world’s largest maker of insulin pen needles and syringes since it was spun off
Study opens up potential to tackle a condition with few available treatment options
Patients who took Sanofi’s lixisenatide experienced no worsening of motor symptoms
Use of medication such as Novo Nordisk’s Ozempic for weight loss sparks supply fears for diabetics
Danish manufacturer of Wegovy invests in two start-ups as part of efforts to stay ahead in major new market
US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits
Danish group has expanded manufacturing capacity but says demand will continue to outstrip supply
Report shows 300% increase in demand for GLP-1 weight loss and diabetes drugs
Pharma group’s decision comes in response to US political pressure over high cost of diabetes medication
Employers are starting to offer coaching to staff in an effort to manage Type 2 diabetes — one of the US’s costliest diseases
Scientists are probing the link between coronavirus and pre-existing co-morbidities
Pandemic response, Alimuddin Zumla on TB, vaccine race
Over 460m people worldwide have diabetes, a figure that is projected to reach 700m by 2045. This report looks at the factors behind this rise, the latest high-tech solutions, and how health services are coping — or failing to
Healthcare workers, scientists and politicians are contending with a big increase in patient numbers
Environment blamed for poorest five-year olds being more likely to be overweight than the richest
Does mix of innovation and continuity of care make type-2 eradication a ‘realistic’ ambition?
Advances in transplantation and medical electronics offer hope to people with type-1 diabetes
The ‘urbanisation of rural life’ may be more significant than migration to cities
‘DIY’ monitoring systems are one answer to regulatory delays
Innovative drugs promise to make life easier — yet many people struggle to afford even insulin
High prices and patchy supplies make life hard for diabetics in the developing world
Absolute advertising ban proposed on high-sugar drinks as part of fight against disease
Livongo prepares IPO as digital healthcare industry offers alternative to tradition
Researchers from MIT and Novo Nordisk have tested tortoise-inspired oral insulin system
